Sanofi Taps Fox Foundation For Parkinson’s Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi and the Michael J. Fox Foundation have teamed up on the development of a treatment for cognitive deficits related to Parkinson’s disease.